Medicolegal Advisory
HealthTech regulatory strategy and risk mitigation for clinical and digital health ventures managing provider compliance obligations.
Med / Law (Hons.)
Strategic Advisor Medicolegal Consultant TGA & Medical Device Regulation

Dr Anna Braganza operates at the point where clinical medicine, regulatory law, and health technology meet. With a background spanning the United Kingdom, the United States, and Australia, she bridges clinical requirements, compliance frameworks, and the commercial realities of scaling inside some of Australia's most regulated healthcare sectors.
Her work with the United Nations and international advisory bodies has given her a close view of how health policy is written, interpreted, and enforced, an understanding she brings down to ground level for the founders and institutions she advises, turning dense regulatory text into decisions that hold up under scrutiny.
Her particular depth is TGA compliance and medical device regulation, guiding devices and digital health products through classification, registration, and the ARTG pathway, alongside close review of clinical claims, so marketing, labelling, and product messaging hold up against the evidentiary standard regulators expect. Few advisors carry both the clinical training to assess the underlying science and the legal training to test it against the regulation itself. Anna's practice sits at that intersection.
Anna advises founders and institutions working in some of the most rigorous professional and regulatory environments.
HealthTech regulatory strategy and risk mitigation for clinical and digital health ventures managing provider compliance obligations.
Guiding devices, diagnostics, and digital health products through TGA classification and registration, with close review of clinical claims to keep them evidence backed and regulator ready.
Discreet, high level health management and advocacy for high net worth individuals and family offices, where clinical judgment and regulatory literacy need to move at the same pace.
Strategic advisory for pre seed and Series A startups entering regulated healthcare and biotechnology, turning clinical and legal complexity into a workable path to scale.
Through an extensive network of institutional partners, Anna is actively involved in deployment across the HealthTech and BioTech sectors, with particular attention to ventures whose regulatory and clinical claims strategy is sound enough to survive diligence.
Submit EnquiryEnquiries regarding medicolegal consultancy, TGA and medical device regulation, regulated market entry, or venture participation are welcome via the form below.